Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Anodic Stimulation in Parkinson's Disease

NCT: NCT07798999 · ACTIVE_NOT_RECRUITING

NCT IDNCT07798999
StatusACTIVE_NOT_RECRUITING
Start Date2026-02-17
Completion2027-02
SponsorUniversity of South Florida (OTHER)
First posted
Last updated

Brief Summary

Randomized, double-blind, crossover design, interventional study to assess the differences between mixed cathodic/anodic, pure cathodic, and pure anodic stimulation with respect to efficacy, side effect thresholds, symptom control, and quality of life in Parkinson's Disease patients implanted with Boston Scientific Cartesia directional DBS leads in the bilateral STN.

Frequently Asked Questions

What is Anodic Stimulation in Parkinson's Disease?

Anodic Stimulation in Parkinson's Disease is a clinical trial registered under NCT07798999. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07798999?

The current status of NCT07798999 (Anodic Stimulation in Parkinson's Disease) is: ACTIVE_NOT_RECRUITING.

When did Anodic Stimulation in Parkinson's Disease start?

Anodic Stimulation in Parkinson's Disease started on 2026-02-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.